Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]

Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplic...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yin P, Li H, Ke C, Cao G, Xin X, Hu J, Cai X, Li L, Liu X, Du B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	aunps poly (i:c) intranasal administration immunogenic cell death in situ immune response activation Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/1e396a273c2e474395861374f3f7c4e7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1e396a273c2e474395861374f3f7c4e7
record_format	dspace
spelling	oai:doaj.org-article:1e396a273c2e474395861374f3f7c4e72021-12-02T12:01:36ZIntranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]1178-2013https://doaj.org/article/1e396a273c2e474395861374f3f7c4e72020-11-01T00:00:00Zhttps://www.dovepress.com/corrigendum-intranasal-delivery-of-immunotherapeutic-nanoformulations--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplicated. The correct Figure 5 is shown below.   The authors apologize for this error and advise it does not affect the results of the paper.   Read the original article  Yin PLi HKe CCao GXin XHu JCai XLi LLiu XDu BDove Medical Pressarticleaunpspoly (i:c)intranasal administrationimmunogenic cell deathin situ immune response activationMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 8873-8874 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	aunps poly (i:c) intranasal administration immunogenic cell death in situ immune response activation Medicine (General) R5-920
spellingShingle	aunps poly (i:c) intranasal administration immunogenic cell death in situ immune response activation Medicine (General) R5-920 Yin P Li H Ke C Cao G Xin X Hu J Cai X Li L Liu X Du B Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
description	Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplicated. The correct Figure 5 is shown below.   The authors apologize for this error and advise it does not affect the results of the paper.   Read the original article
format	article
author	Yin P Li H Ke C Cao G Xin X Hu J Cai X Li L Liu X Du B
author_facet	Yin P Li H Ke C Cao G Xin X Hu J Cai X Li L Liu X Du B
author_sort	Yin P
title	Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_short	Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_full	Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_fullStr	Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_full_unstemmed	Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_sort	intranasal delivery of immunotherapeutic nanoformulations for treatment of glioma through in situ activation of immune response [corrigendum]
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/1e396a273c2e474395861374f3f7c4e7
work_keys_str_mv	AT yinp intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT lih intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT kec intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT caog intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT xinx intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT huj intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT caix intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT lil intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT liux intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum AT dub intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
_version_	1718394735686582272

Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]

Ejemplares similares